Highland Capital Management Fund Advisors, L.P. Vor Biopharma Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$761 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$12.24 - $20.38 $612,000 - $1.02 Million	-50,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.65 - $38.78 $932,499 - $1.94 Million	50,000 New	50,000 $933,000

Others Institutions Holding VOR

# of Institutions

Shares Held

47.9M

Call Options Held

1.5K

Put Options Held

Ra Capital Management, L.P. Boston, MA

22.7M
Shares

$15.9 Million
0.34% of portfolio
Paradigm Biocapital Advisors LP New York, NY

6.46M
Shares

$4.52 Million
0.26% of portfolio
5 Am Venture Management, LLC San Francisco, CA

6.36M
Shares

$4.45 Million
2.98% of portfolio
Laurion Capital Management LP New York, NY

2.53M
Shares

$1.77 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$1.37 Million
0.0% of portfolio

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $26.6M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account